Pharmaceutical Executive

🚨Our December issue is LIVE🚨 A Rocky Road for Regulation 🔷 DTC's New Era of Engagement 🔷 Seeking More Value, Less Cost 🔷 Margaret Keegan, the new CEO of Precision Medicine Group shares Pharma's Best Kept Secret 🔷 and so much more right here! ➡️ https://lnkd.in/dq4PvaR7

In this exclusive podcast, Dr. Lawrence B. Werlin (@md.lawrence.werlin on TikTok) tackles fertility misinformation, the power of accurate info, ethical concerns in sharing online, and more! Listen to the podcast: https://ow.ly/PrjE50UQiiA

In early phase trials innovative designs offer potential for improvements in efficiency and decision-making🖊️Dr. Tim Clark, Dip. Stat., Vice-President, Clinical Sciences, and Karen L Smith, Director, Biostatistical Consulting Services, ICON plc

CVS Health's new app provides user with more features, including an AI-powered search, than the pharmacy’s previous app.

📹 Greg Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the immediate impact Spravato ® has had on patients with #treatmentresistantdepression

📹 Nancy Ghattas, VP, US franchise head, imunno-oncology, gastrointestinal tumors, AstraZeneca, discusses the promising results from the ADRIATIC trial, in which patients were treated with Imfinzi for limited-stage #smallcelllungcancer

Due to the rising influence of payers in the US healthcare system, today’s pharma commercial teams have a more significant influence on clinical trial and real-world evidence study design than ever before. To be an effective partner to the clinical and scientific teams tasked with managing these trials and studies, commercial professionals must understand precisely what payers need and how to generate the data that will build a value story that is meaningful to them. How training can help: Educating teams on foundational elements of coverage criteria and trial/study design creates a richer understanding of what payers want and how to give it to them. To be comprehensive, training should also include deep dives into fiscal efficiencies, endpoint nuances, and how to maximize the value of a pipeline. Read more about overcoming six common pain points troubling pharma in 2025 in this Pharmaceutical Executive article by Diane Petrone: https://lnkd.in/exHGsPEB #pharma #biotech #traininganddevelopment #marketaccess #elevateandaccelerate #rwe #realworldevidence #clinicaltrials

Calling all rising stars in pharma and biotech! The 2025 Emerging Pharma Leaders Awards are here to celebrate the next generation of trailblazers shaping the future of our industry. Nominate yourself or someone you admire who embodies leadership, innovation, and vision. Are they c-suite bound? Do they inspire others while navigating the complexities of R&D, marketing, sales, or market access? This is your chance to spotlight the leaders of tomorrow. Submit your nomination today: https://ow.ly/4qgm50UOZ4e #PharmaLeaders #EmergingLeaders #PharmaInnovation

The European Medicines Agency’s Committee for Medicinal Products for Human Use recently issued a positive opinion for the use of #Omvoh for the treatment of moderate to severe Crohn’s in adults. Mark Genovese, MD, senior vice president at Eli Lilly and Company Immunology Development, spoke with Pharmaceutical Executive about the importance of developing medicines that treat disruptive symptoms of chronic conditions.